COVID-19, a natural experiment. Did it create an opportunity to reduce racial disparities in psychosocial oncology and change how we deliver care?

Publication date: Feb 06, 2025

There is evidence to support the acceptability of telehealth among oncology patients, but inconsistencies regarding access and use in underserved populations. This study used the COVID-19 pandemic as a natural experiment to test whether implementation of telehealth for patients referred to a psychosocial oncology (PSO) service would 1) increase PSO access and utilization and 2) reduce racial disparities. Demographic, medical and appointment completion data for patients referred to a PSO service at an NCI-Designated Comprehensive Cancer Center from March, 2018 to March, 2022 were examined. Descriptive and multivariate logistical regression analyses at both the patient and visit level were conducted. Outcomes were patient follow-up (i. e. ≥ one scheduled PSO appointment) and visit outcome (completed vs. canceled/no-show). The sample included 934 White and 610 Black adult patients (69. 8% female) aged 18-95 (M = 56. 0, SD = 15. 3) who scheduled 5,782 PSO visits. Follow-up rates significantly increased post-COVID among White (66. 2%-72. 2%; Z = 2. 17, p = . 03), but not Black patients (73. 6%-70. 4%; Z = 0. 88, p = . 38). Among N = 1,089 patients who scheduled at least one PSO appointment, telehealth had a significant effect on visit outcomes (X = 466. 6, df = 2, p 

Concepts Keywords
Canceled COVID-19
Pandemic populations
Underserved Psychosocial oncology
telehealth
vulnerable

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Cancer

Original Article

(Visited 2 times, 1 visits today)